Higher serum concentrations of dietary antioxidants are associated with lower levels of inflammatory biomarkers during the year after hip fracture

Clin Nutr. 2012 Oct;31(5):659-65. doi: 10.1016/j.clnu.2012.01.013. Epub 2012 Feb 25.

Abstract

Background & aims: Chronic inflammation impairs recovery among the 1.6 million people who suffer from hip fracture annually. Vitamin E and the carotenoids are two classes of dietary antioxidants with profound anti-inflammatory effects, and the goal of this study was to assess whether higher post-fracture concentrations of these antioxidants were associated with lower levels of interleukin 6 (IL-6) and the soluble receptor for tumor necrosis factor-alpha (sTNF-αR1), two common markers of inflammation.

Methods: Serum concentrations of the dietary antioxidants and inflammatory markers were assessed at baseline and 2, 6, and 12 month follow-up visits among 148 hip fracture patients from The Baltimore Hip Studies. Generalized estimating equations modeled the relationship between baseline and time-varying antioxidant concentrations and inflammatory markers.

Results: Higher post-fracture concentrations of vitamin E and the carotenoids were associated with lower levels of inflammatory markers. Associations were strongest at baseline, particularly between the α-tocopherol form of vitamin E and sTNF-αR1 (p = 0.05) and total carotenoids and both sTNF-αR1(p = 0.01) and IL-6 (p = 0.05). Higher baseline and time-varying α-carotene and time-varying lutein concentrations were also associated with lower sTNF-αR1 at all post-fracture visits (p ≤ 0.05).

Conclusions: These findings suggest that a clinical trial increasing post-fracture intake of vitamin E and the carotenoids may be warranted.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Antioxidants / analysis*
  • Baltimore
  • Biomarkers / blood
  • Carotenoids / blood
  • Chronic Disease
  • Diet*
  • Female
  • Hip Fractures / blood*
  • Hip Fractures / complications
  • Humans
  • Inflammation / blood*
  • Inflammation / complications
  • Interleukin-6 / blood
  • Longitudinal Studies
  • Lutein / blood
  • Randomized Controlled Trials as Topic
  • Tumor Necrosis Factor-alpha / blood
  • Vitamin E / blood

Substances

  • Antioxidants
  • Biomarkers
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Vitamin E
  • Carotenoids
  • Lutein